CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
CELZ$5M
Micro CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaPHOENIX4 employees
Drugs in Pipeline
3
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Q1 2027
Market Overview
Stock performance and key metrics
CELZ News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
CELZ-201 Administration
Type 1 Diabetes
CELZ-201-DDT
Chronic Low-back Pain
C-peptide
Diabetes Mellitus, Type 1
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
CELZ-201 Administration | Phase 2 | Type 1 Diabetes | - | - |
CELZ-201-DDT | Phase 2 | Chronic Low-back Pain | - | - |
C-peptide | Phase 2 | Diabetes Mellitus, Type 1 | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply